Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Pharmacokinetic of IBI3011 [Phase 1]

View source ↗

Summary

A Phase 1 study to evaluate the safety, tolerability, and pharmacokinetics of IBI3011 in participants with an acute gout flare; the trial is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout Flare

Drugs mentioned

• IBI3011

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Acute Gout Flare | Phase 1 | Status: RECRUITING